Teen seeks $250,000 for trial drug after tumor diagnosis

Joscelyne Kerr, 19, was diagnosed with a rare brain tumor after noticing her pupil had expanded. Initially thought to be a neurological disorder, further tests revealed a schwannoma tumor on her third ocular nerve, which is extremely uncommon. After surgery to remove 90% of the tumor, complications led to memory and muscle function loss. A biopsy later confirmed an aggressive cancer with a prognosis of 12-18 months, prompting her to undergo chemotherapy and radiotherapy, which were ineffective. Kerr is now raising funds for a trial drug, DCVax-L, costing £250,000, which shows promise for her condition. She has raised nearly £100,000 so far and is advocating for more research on brain tumors.